(Q54946764)

English

PD PaCa

cell line

PDPaCa
Poorly Differentiated Pancreatic adenoCarcinoma
PD

In more languages

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

described by source

Comparison of the cellular pharmacology of doxorubicin in resistant and sensitive models of pancreatic cancer.

1 reference

Cellosaurus release 49

14 July 2024

Inhibition of growth of human or hamster pancreatic cancer cell lines by alpha-difluoromethylornithine alone and combined with cis-diamminedichloroplatinum(II).

1 reference

Cellosaurus release 49

14 July 2024

Chemotherapy of pancreatic adenocarcinoma: initial report on two transplantable models in the Syrian hamster

1 reference

Cellosaurus release 49

14 July 2024

K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

hamster pancreatic ductal adenocarcinoma

1 reference

Cellosaurus release 49

14 July 2024

derived from organism type

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54946764&oldid=2204392385"